淫羊藿苷经miR-23b干预激素性骨微血管内皮细胞损伤的机制研究

基本信息
批准号:81673776
项目类别:面上项目
资助金额:50.00
负责人:郭万首
学科分类:
依托单位:中日友好医院
批准年份:2016
结题年份:2020
起止时间:2017-01-01 - 2020-12-31
项目状态: 已结题
项目参与者:杨兴林,程立明,王佰亮,张启栋,赵丁岩,黄振国,马路遥,陈有荣
关键词:
miR23b内皮细胞淫羊藿苷股骨头坏死
结项摘要

Disordered circulation in bone is the key etiological factor for glucocorticoids-induced osteonecrosis of femoral head. Injury of bone microvascular endothelial cells hereby is the critical factor. miRNAs were found to play important roles in regulating vascular endothelial cells’ function. The applicant has studied the influence of glucocorticoids on bone microvascular endothelial cells, especially via transcriptome of miRNAs. The previous study was supported by the national natural science fund 81273972 and found that miR-23b in bone microvascular endothelial cells was significantly influenced by glucocorticoids. After information analysis with multiple databases including miRWalk, miR-23b was found to have significant effect on many intracellular signal transduction factors, such as Sprouty2, Sema6A, Sema6D, Apaf-1, TNFAIP1, TNFAIP2, TNFAIP3. These factors comprehensively affected bone microvascular endothelial cells and osteocyts, involving several signal transduction pathways such as apoptosis pathway and angiogenesis. As for the pathogenesis of glucocorticoids-induced damage to endothelial cells, miR-23b is supposed to play an important role in BMECs by certain signal pathways. In this study, we plan to qualify the effect of miR-23b on BMECs injury induced by glucocorticosteroids, along with its downstream coordinates. Therefore we would clarify the mechanism beneath the regulatory axis, i.e. miRNAs-target genes-differentially expressed proteins. Moreover, we will qualify the effect of icariin upon the expression levels of miR-23b and its downstream coordinates. Finally, we will define the regulation pathway of miR-23b and reveal the mechanism how icariin protect the bone microvascular endothelial cells from injury induced by glucocorticoids.

血供障碍是激素性股骨头坏死的病理基础,骨微血管内皮细胞(BMECs)损伤是关键环节,机制尚不明。我们前期研究发现,激素明显引起BMECs miR-23b下调,而有“补肾壮骨”功效的淫羊藿苷对激素性BMECs损伤有保护作用,且上调miR-23b表达。经靶点预测,miR-23b调控多种细胞因子,涉及细胞凋亡和血管生成等信号通路。淫羊藿苷是否经miR-23b调控上述通路起保护作用?值得深入研究。本项目拟用激素性BMECs损伤模型及兔激素性股骨头坏死模型,通过miR-23b高表达/敲减系统研究miR-23b对激素性BMECs损伤信号通路的调控作用,并通过萤光素酶报告基因系统进一步验证其分子靶点,揭示miR-23b调控激素性BMECs损伤的分子机制。通过淫羊藿苷干预BMECs损伤中miR-23b及其下游分子的研究,揭示淫羊藿苷保护激素性BMECs损伤的机制及靶点,诠释中医“肾主骨”理论的科学内涵。

项目摘要

骨微血管内皮细胞(BMECs)损伤是激素性股骨头坏死的密切相关,其机制尚不明。前期研究发现,激素明显引起BMECs miR-23b下调,而淫羊藿苷对激素性BMECs损伤有保护作用,且上调miR-23b表达。淫羊藿苷是否经miR-23b调控上述通路起保护作用值得深入研究。我们进行了BMECs全转录组测序分析,体外验证了ICA通过miRNA-222调控BMECs的成血管分化作用机制研究,连接介导和调控Y蛋白(JMY)在糖皮质激素(GC)诱导内皮细胞凋亡及迁移抑制中的作用机制,研究了miR-23b对激素性股骨头坏死发生和血管生成的影响,及对BMECs损伤的作用及相关信号通路。构建miR-23b调控的分子靶点的启动子重组质粒,通过萤光素酶报告基因系统,验证miR-23b对上述靶点的调控作用。我们初步筛选了具有表达差异的miRNA,lncRNA circRNA,明确了ICA通过miRNA-222调控BMECs的成血管分化作用机制,以及JMY在HUVEC经GC诱导损伤的发病机理,揭示了miR-23b在激素性BMECs损伤中的可能信号作用通路为VEGF-AKT通路,分析其对BMECs凋亡及血管生成的影响,通过研究淫羊藿苷干预激素性股骨头坏死模型中miR-23b及其下游分子的变化,揭示淫羊藿苷对激素性BMECs损伤起保护作用的分子机制及作用靶点。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

转录组与代谢联合解析红花槭叶片中青素苷变化机制

转录组与代谢联合解析红花槭叶片中青素苷变化机制

DOI:
发表时间:
2

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

DOI:10.1002/cam4.1029.
发表时间:2017
3

肉苁蓉种子质量评价及药材初加工研究

肉苁蓉种子质量评价及药材初加工研究

DOI:10.11842/wst.2017.02.019
发表时间:2017
4

Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy

Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy

DOI:10.3389/fcell.2021.650666
发表时间:2021
5

骨髓间充质干细胞源外泌体调控心肌微血管内皮细胞增殖的机制研究

骨髓间充质干细胞源外泌体调控心肌微血管内皮细胞增殖的机制研究

DOI:10.16016/j.1000-5404.201907063
发表时间:2019

相似国自然基金

1

基于Hippo和TGFβ通路交叉对话对淫羊藿苷干预激素性股骨头坏死微血管内皮细胞损伤的研究

批准号:81703896
批准年份:2017
负责人:张启栋
学科分类:H3302
资助金额:20.00
项目类别:青年科学基金项目
2

MSCs外泌体调控ERS介导的骨微血管内皮细胞凋亡干预激素性骨坏死的分子机制研究

批准号:81772350
批准年份:2017
负责人:王佰亮
学科分类:H0604
资助金额:25.00
项目类别:面上项目
3

活性小分子淫羊藿苷(Icariin)通过调控Hippo-YAP通路干预骨骺损伤的作用及其机制研究

批准号:81572094
批准年份:2015
负责人:郭风劲
学科分类:H0601
资助金额:57.00
项目类别:面上项目
4

淫羊藿苷-力学耦合作用对抗骨疲劳损伤的机理研究

批准号:31500761
批准年份:2015
负责人:王强松
学科分类:C1001
资助金额:20.00
项目类别:青年科学基金项目